These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27167827)

  • 1. Photoimmunotherapy of residual disease after incomplete surgical resection in head and neck cancer models.
    Moore LS; de Boer E; Warram JM; Tucker MD; Carroll WR; Korb ML; Brandwein-Gensler MS; van Dam GM; Rosenthal EL
    Cancer Med; 2016 Jul; 5(7):1526-34. PubMed ID: 27167827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.
    Sato K; Watanabe R; Hanaoka H; Harada T; Nakajima T; Kim I; Paik CH; Choyke PL; Kobayashi H
    Mol Oncol; 2014 May; 8(3):620-32. PubMed ID: 24508062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.
    Railkar R; Krane LS; Li QQ; Sanford T; Siddiqui MR; Haines D; Vourganti S; Brancato SJ; Choyke PL; Kobayashi H; Agarwal PK
    Mol Cancer Ther; 2017 Oct; 16(10):2201-2214. PubMed ID: 28619755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.
    Okada R; Kato T; Furusawa A; Inagaki F; Wakiyama H; Fujimura D; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H
    Cancer Immunol Immunother; 2022 Aug; 71(8):1877-1887. PubMed ID: 35013765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging.
    Maruoka Y; Nagaya T; Nakamura Y; Sato K; Ogata F; Okuyama S; Choyke PL; Kobayashi H
    Mol Pharm; 2017 Dec; 14(12):4628-4635. PubMed ID: 29135265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials.
    Okada R; Furusawa A; Vermeer DW; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Spanos WC; Allen CT; Kobayashi H
    EBioMedicine; 2021 May; 67():103345. PubMed ID: 33933782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photoimmunotherapy Inhibits Tumor Recurrence After Surgical Resection on a Pancreatic Cancer Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
    Hiroshima Y; Maawy A; Zhang Y; Guzman MG; Heim R; Makings L; Luiken GA; Kobayashi H; Tanaka K; Endo I; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1469-74. PubMed ID: 25893411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging.
    Nakajima T; Sano K; Mitsunaga M; Choyke PL; Kobayashi H
    Cancer Res; 2012 Sep; 72(18):4622-8. PubMed ID: 22800710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen.
    Nagaya T; Sato K; Harada T; Nakamura Y; Choyke PL; Kobayashi H
    PLoS One; 2015; 10(8):e0136829. PubMed ID: 26313651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy.
    Mitsunaga M; Nakajima T; Sano K; Kramer-Marek G; Choyke PL; Kobayashi H
    BMC Cancer; 2012 Aug; 12():345. PubMed ID: 22873679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor (EGFR) density may not be the only determinant for the efficacy of EGFR-targeted photoimmunotherapy in human head and neck cancer cell lines.
    Peng W; de Bruijn HS; Farrell E; Sioud M; Mashayekhi V; Oliveira S; van Dam GM; Roodenburg JLN; Witjes MJH; Robinson DJ
    Lasers Surg Med; 2018 Jul; 50(5):513-522. PubMed ID: 29777587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the efficacy of Photoimmunotherapy (PIT) using a cocktail of antibody conjugates in a multiple antigen tumor model.
    Nakajima T; Sano K; Choyke PL; Kobayashi H
    Theranostics; 2013; 3(6):357-65. PubMed ID: 23781283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photoimmunotherapy lowers recurrence after pancreatic cancer surgery in orthotopic nude mouse models.
    Maawy AA; Hiroshima Y; Zhang Y; Garcia-Guzman M; Luiken GA; Kobayashi H; Hoffman RM; Bouvet M
    J Surg Res; 2015 Jul; 197(1):5-11. PubMed ID: 25799527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The feasibility of Miltuximab®-IRDye700DX-mediated photoimmunotherapy of solid tumors.
    Polikarpov DM; Campbell DH; Lund ME; Lu Y; Lu Y; Wu J; Walsh BJ; Zvyagin AV; Gillatt DA
    Photodiagnosis Photodyn Ther; 2020 Dec; 32():102064. PubMed ID: 33069874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic fluorescent imaging with indocyanine green for monitoring the therapeutic effects of photoimmunotherapy.
    Ali T; Nakajima T; Sano K; Sato K; Choyke PL; Kobayashi H
    Contrast Media Mol Imaging; 2014; 9(4):276-82. PubMed ID: 24706611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT).
    Siddiqui MR; Railkar R; Sanford T; Crooks DR; Eckhaus MA; Haines D; Choyke PL; Kobayashi H; Agarwal PK
    Sci Rep; 2019 Feb; 9(1):2084. PubMed ID: 30765854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases.
    Inagaki FF; Wakiyama H; Furusawa A; Okada R; Kato T; Fujimura D; Okuyama S; Fukushima H; Takao S; Choyke PL; Kobayashi H
    Biomed Pharmacother; 2023 Apr; 160():114390. PubMed ID: 36791566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT).
    Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H
    J Control Release; 2016 Jun; 232():1-8. PubMed ID: 27059723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A standardized light-emitting diode device for photoimmunotherapy.
    de Boer E; Warram JM; Hartmans E; Bremer PJ; Bijl B; Crane LM; Nagengast WB; Rosenthal EL; van Dam GM
    J Nucl Med; 2014 Nov; 55(11):1893-8. PubMed ID: 25315245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trastuzumab-based near-infrared photoimmunotherapy in xenograft mouse of breast cancer.
    Yamashita S; Kojima M; Onda N; Yoshida T; Shibutani M
    Cancer Med; 2023 Feb; 12(4):4579-4589. PubMed ID: 36259134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.